P
Pengyang Medical
A health care service provider
About Pengyang Medical
Established in 2004, Pengyang Medical, formerly known as Beijing Pengyang Fengye Medical Equipment Co., Ltd., is a privately held diagnostic equipment company headquartered in Beijing, China. The firm specializes in developing advanced electrocardiogram (ECG) technology aimed at providing detailed cardiovascular information to practitioners, thereby reducing the potential for misdiagnosis. Its core product is the Medsun 18-lead ECG analysis system, which offers a significant advancement over traditional 12-lead systems.
The 18-lead ECG system is engineered to synchronously monitor the electrical activity across multiple heart regions, including the anterior-septal, anterior, anterolateral, high lateral, right ventricular, and posterior walls. This comprehensive monitoring capability significantly improves the detection rate of myocardial ischemia and is instrumental in identifying the specific coronary arteries involved in a cardiac event. The system incorporates aerospace-grade materials and features built-in technology to detect changes in body position, enhancing diagnostic accuracy. The company's products have received both FDA and ISO certifications, underscoring their adherence to international quality and safety standards.
Pengyang Medical has successfully navigated multiple funding rounds to support its growth and product development. After a Series A round in July 2018 and a Series B round in June 2022, the company secured an additional $1.41 million in a Series B2 round in January 2024. Its investor base includes notable entities such as Wuzhong Economic Development Zone Venture Guidance Fund, Jiuwei Asset, Yi Kun Ventures, and CCB International. The company is currently generating revenue and is positioned within a competitive market of diagnostic equipment manufacturers.
Source: Dealroom company dataNews
Open roles
Pengyang Medical in the Dongcheng District ecosystem
The Pengyang Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
CCB International- WIWuzhong Jingkai Intelligent Manufacturing Investment
- WIWuzhong Economic and Technological Innovation Investment
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Pengyang Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Pengyang Medical on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


